VIM and metastatic malignant neoplasm in the lymph nodes: Markedly, patients with loss of vimentin were more often diagnosed with deep myometrial infiltration (≥50%, Chi-share, P < 0.001), lymph node metastases (Chi-square, P = 0.001), and disease recurrence (Chi-square, P < 0.001).